|
Total |
Mild-moderate group |
Severe group |
Number of patients |
86 |
11 |
75 |
Gender (male/female) |
57/29 |
6/5 |
51/24 |
Median (range) age, month |
35 (1-198) |
14 (3-109) |
35
(1-198) |
Median (range) platelet count, ×109/L |
5 (0-10) |
7
(1-10) |
5 (0-10) |
Median (range) bleeding scores |
2 (0-3) |
1 (0-2) |
2
(0-3) |
Platelet antibodies |
|
|
|
anti-GPIIb/IIIa (+), anti-GPIb/IX (+) |
52 |
6 |
46 |
anti-GPIIb/IIIa (+), anti-GPIb/IX (-) |
7 |
0 |
7 |
anti-GPIIb/IIIa (-), anti-GPIb/IX (+) |
4 |
1 |
3 |
anti-GPIIb/IIIa (-), anti-GPIb/IX (-) |
23 |
4 |
19 |